SITC gratefully acknowledges the following supporters of the society's 33rd Annual Meeting & Pre-Conference Programs.
33rd Annual Meeting
Double Platinum
AstraZeneca Pharmaceuticals LP
Platinum
Bristol-Myers Squibb
Merck & Co., Inc.
Gold
AbbVie
Amgen Inc.
Genentech
Incyte Corporation
Janssen Research & Development, LLC
Novartis Oncology
Silver
Gilead Sciences
Lilly Oncology
TESARO, Inc.
Bronze
Bavarian Nordic A/S
Bayer HealthCare Pharmaceuticals Inc.
Celgene Corporation
NanoString Technologies
(The CheckPoints Party)Pfizer, Inc.
Regeneron Pharmaceuticals
Copper
7 Hills Pharma
(The CheckPoints Party)
Astellas and Seattle Genetics
Fluidigm
(The CheckPoints Party)
HalioDx
(The CheckPoints Party)Novartis Pharmaceuticals Corporation
The Parker Institute for Cancer Immunotherapy
Prometheus Laboratories Inc.
Replimune
Primer on Tumor Immunology and Cancer ImmunotherapyTM
Gold
AstraZeneca Pharmaceuticals LP
Silver
Incyte Corporation
Merck & Co., Inc.
Bronze
Bristol-Myers Squibb
Celgene Corporation
Workshop on Nutrition, Metabolism, and the Microbiome in Cancer Therapy
Platinum
AstraZeneca Pharmaceuticals LP
Bronze
Celgene Corporation
Copper
The Parker Institute for Cancer Immunotherapy
Industry Program
Gold
Bristol-Myers Squibb
Genentech
Silver
AbbVie, Inc.
AstraZeneca Pharmaceuticals LP
Merck & Co., Inc.
Bronze
Celgene Corporation
Gilead Sciences
NanoString Technologies
Grant Writing: From Start to Finish, and then Starting Again
Bronze
AstraZeneca Pharmaceuticals LP